Reportes de Congresos | ||
OBESITY WEEK: Bariatric surgery in transplant patients
as presented at the annual joint meeting of the Obesity Society and the American Society for Metabolic & Bariatric Surgery
Bariatric surgery represents a valid therapeutic option for patients who become morbidly obese after liver, kidney, and pancreas transplantation as well as failed nonsurgical therapies, according to a poster at Obesity Week, held in November in Boston.
The study described a total of 409 consecutive patients who underwent minimally invasive sleeve gastrectomy as one-stage surgery at the University of Illinois at Chicago Medical Center from January 2008 to January 2014. Out of the 409 patients, six had a previous kidney transplant, two had a previous liver transplant, and another had a pancreas transplant.
The mean age of the transplant patients was 50.5 and the mean preoperative BMI 48.54 Kg/m2. The average operative time was 72.5 minutes. The mean length of stay was 4.5 days. According to the study authors, there were no complications and no conversions to open; no operations were registered in these patients. Further, immunosuppressive therapy was not modified after surgery. There were no postoperative complications and no complications related to the graft. The mean excess weight loss at 12 months follow-up was 51.2.
“Sleeve gastrectomy is a feasible technique with good postoperative outcomes as a bariatric procedure after orthotropic liver, kidney and pancreas transplantation,” the authors concluded. “This surgery doesn’t increase perioperative risk in those patients.”
----
No hay comentarios:
Publicar un comentario